Completed NA INTERVENTIONAL 2-arm NCT06218537

The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy (AERATE)

Sponsor: Carol Davila University of Medicine and Pharmacy

Conditions Upper Gastrointestinal Endoscopy

Updated 5 times since 2024 Last updated: Nov 9, 2024 Started: Aug 1, 2024 Primary completion: Aug 31, 2024 Completion: Aug 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06218537, this NA trial focuses on Upper Gastrointestinal Endoscopy and remains completed. Sponsored by Carol Davila University of Medicine and Pharmacy, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Dec 2024 — Present [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2024 — Dec 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jun 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2024 — Jun 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Carol Davila University of Medicine and Pharmacy

Data source: Carol Davila University of Medicine and Pharmacy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bucharest, Romania